Acoltremon

Acoltremon

SCHEMBL3228667

COc1ccc(NC(=O)[C@H]2C[C@H](C)CC[C@H]2C(C)C)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 4/20 1.00
TRPV1 Q8NER1 2/20 0.57
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
HPGD P15428 2/20 0.47
POLB P06746 1/20 0.47
EPHX1 P07099 1/20 0.47
ALDH1A1 P00352 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
EPHX2 P34913 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
USP2 O75604 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acoltremon SCHEMBL29570327 1.00 TRPM8 (1.00) TRPM8TRPV1MEN1KMT2ANPC1
Acoltremon SCHEMBL29225639 1.00 TRPM8 (1.00) TRPM8TRPV1MEN1KMT2ANPC1
Acoltremon SCHEMBL2575067 1.00 TRPM8 (1.00) TRPM8TRPV1MEN1KMT2ANPC1
Acoltremon SCHEMBL619824 1.00 TRPM8 (1.00) TRPM8TRPV1MEN1KMT2ANPC1
Acoltremon SCHEMBL23870506 1.00 TRPM8 (1.00) TRPM8TRPV1MEN1KMT2ANPC1
Acoltremon SCHEMBL23198293 1.00 TRPM8 (1.00) TRPM8TRPV1MEN1KMT2ANPC1
Acoltremon SCHEMBL14811473 1.00 TRPM8 (1.00) TRPM8TRPV1MEN1KMT2ANPC1
Acoltremon SCHEMBL17104729 1.00 TRPM8 (1.00) TRPM8TRPV1MEN1KMT2ANPC1
Acoltremon SCHEMBL16227989 1.00 TRPM8 (1.00) TRPM8TRPV1MEN1KMT2ANPC1
SCHEMBL2628780 0.88 TRPM8 (0.78) TRPM8TRPV1KMT2AHPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240165004-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2024-05-23 US claimed
EP-4304550-A1 ORGANIC COMPOUNDS Givaudan SA (CH) 2024-01-17 EP claimed
WO-2022189383-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2022-09-15 WO claimed
EP-2318356-B1 SYNTHESIS OF CYCLOHEXANE DERIVATIVES USEFUL AS SENSATES IN CONSUMER PRODUCTS PROCTER & GAMBLE (US) 2015-03-11 EP claimed
US-8426643-B2 Synthesis of cyclohexane derivatives useful as sensates in consumer products THE PROCTER & GAMBLE COMPANY (US) 2013-04-23 US claimed
US-20100076080-A1 Synthesis of Cyclohexane Derivatives Useful as Sensates in Consumer Products THE PROCTER & GAMBLE COMPANY 2010-03-25 US claimed
US-20240165004-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2024-05-23 US disclosed
EP-4304550-A1 ORGANIC COMPOUNDS Givaudan SA (CH) 2024-01-17 EP disclosed
WO-2022189383-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2022-09-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240165004-A1 ORGANIC COMPOUNDS TAS2R8, TAS2R10, TAS2R20 TRPM8 58/4885TRPV1 83/4885MEN1 3178/4885
US-20100076080-A1 Synthesis of Cyclohexane Derivatives Useful as Sensates in Consumer Products NISCH, TRPM4, TRPM8 TRPM8 3/4885TRPV1 12/4885MEN1 1170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.